ARTL stock Statistics — Artelo Biosciences, INC. filings, insiders & smart money

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Beta: Sign in
Shares outstandingAs of 2026-08-11 · filed common shares: 4.59M
Shares float: Sign in
Float %: Sign in
Insider ownership: —
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 0.78%
Short ratioDays to cover, as published by FINRA: 1.00
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 48.70%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 55.40%
Avg volume (10D)

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Gross margin: —
Operating margin: —
Net margin: —
EBITDA margin: —
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: -705.71%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: -234.30%

Cash & equivalentsas of Jun 26: $4.19M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $49.00K
Debt / equityas of Jun 26: 0.98%
Current ratioas of Jun 26: 3.00
Quick ratio: —
Operating cash flowTTM to Jun 26: -$12.63M
Free cash flow (nine months)Nine months: 2025-01-01 to 2025-09-30 · Not annualized: -$5.60M
TTM revenue / diluted share: —